COVID-19患者胸椎骨折高发并可预测疾病结局
意大利San Raffaele医院回顾性纳入114例急诊行侧位胸片的COVID-19患者,用半定量法评估椎体形态。41例(36%)检出胸椎骨折;骨折组年龄更大、高血压与冠心病更多,更常用无创机械通气,重度骨折者死亡率更高。作者建议对行胸片的疑似COVID-19患者常规行胸椎形态学评估。
要点
- COVID-19患者胸椎骨折检出率达36%,提示脆性负担常被低估。
- 椎体骨折与年龄、高血压、冠心病及无创通气需求相关。
- 重度椎体骨折者死亡率高于轻中度者,或可辅助风险分层。
核心结论
- 胸椎骨折可整合进COVID-19患者的心肺风险评估,是易测量且提示脆弱与不良预后的临床标志。
研究设计与样本
- 意大利三级医院San Raffaele医院开展的回顾性队列研究,纳入急诊时具有侧位胸片资料的COVID-19患者,共114例。
- 椎体骨折采用胸片椎体形态的半定量评估检出。
主要发现
- 114例中41例(36%)检出胸椎骨折。
- 骨折组年龄更大,高血压(P<0.001)与冠心病(P=0.034)更常见。
- 骨折组更常需要无创机械通气(P=0.02)。
- 死亡率骨折组22%、无骨折组10%(P=0.07);重度骨折者死亡率高于中度与轻度骨折者(P=0.04)。
关键数值与推荐
- 椎体骨折检出41/114例(36%)。
- 住院比例骨折组36例(88%)、无骨折组54例(74%),P=0.08。
- 死亡率骨折组22%、无骨折组10%,P=0.07;重度对比中度与轻度骨折P=0.04。
临床怎么用
- 对行胸片的疑似COVID-19患者可顺带进行胸椎形态学评估,以识别脆性与不良预后风险。
局限性
- 单中心回顾性设计,样本量114例,仅纳入有急诊侧位胸片者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT AND OBJECTIVE: COVID-19 has become the most relevant medical issue globally. Despite several studies that have investigated clinical characteristics of COVID-19 patients, no data have been reported on the prevalence of vertebral fractures (VFs). Since VFs may influence cardiorespiratory function and disease outcomes, the aim of this study was to assess VFs prevalence and clinical impact in COVID-19. DESIGN AND PATIENTS: This was a retrospective cohort study performed at San Raffaele Hospital, a tertiary health care hospital in Italy. We included COVID-19 patients for whom lateral chest x-rays at emergency department were available. VFs were detected using a semiquantitative evaluation of vertebral shape on chest x-rays. RESULTS: A total of 114 patients were included in this study and thoracic VFs were detected in 41 patients (36%). Patients with VFs were older and more frequently affected by hypertension and coronary artery disease (P < 0.001, P = 0.007, P = 0.034; respectively). Thirty-six (88%) patients in VFs+ group compared to 54 (74%) in VFs- group were hospitalized (P = 0.08). Patients with VFs more frequently required noninvasive mechanical ventilation compared with those without VFs (P = 0.02). Mortality was 22% in VFs+ group and 10% in VFs- group (P = 0.07). In particular, mortality was higher in patients with severe VFs compared with those with moderate and mild VFs (P = 0.04). CONCLUSIONS: VFs may integrate the cardiorespiratory risk of COVID-19 patients, being a useful and easy to measure clinical marker of fragility and poor prognosis. We suggest that morphometric thoracic vertebral evaluation should be performed in all suspected COVID-19 patients undergoing chest x-rays.
引用
- di Filippo L, Formenti AM, Doga M, et al. Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes. J Clin Endocrinol Metab. 2021. PMID: 33159451. doi:10.1210/clinem/dgaa738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。